股本结构
单位：万股
| 公告日期 | 2025-11-14 | 2025-11-12 | 2025-11-12 | 2025-08-28 | 2025-08-13 | 2025-08-13 |
|---|---|---|---|---|---|---|
| 证券总股本 | 152.66 | 2900.62 | 2680.10 | 2655.49 | 2653.39 | 2644.33 |
| 普通股本 | 152.66 | 2900.62 | 2680.10 | 2655.49 | 2653.39 | 2644.33 |
| 优先股 | 未披露 | 未披露 | 14.75 | 14.75 | 未披露 | 14.77 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2025-11-25 | 2025-11-11 | 2025-09-30 | 2025-08-22 | 2025-08-11 | 2025-06-30 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2025-11-14 | 152.66 | 未披露 |
更多>>
a one-for-nineteen reverse split of the Company's common stock
|
2025-11-25 |
| 2025-11-12 | 2900.62 | 未披露 | 定期报告 | 2025-11-11 |
| 2025-11-12 | 2680.10 | 14.75 |
更多>>
From June 30, 2025 to September 30, 2025
Conversion of Redeemable Convertible Preferred Shares into Common Stock
Exercise of Private Pre-Funded Warrants
Issuance of Common Stock under At the Market Sales Agreement, net of $3 issuance costs
|
2025-09-30 |
| 2025-08-28 | 2655.49 | 14.75 | 定期报告 | 2025-08-22 |
| 2025-08-13 | 2653.39 | 未披露 | 定期报告 | 2025-08-11 |
| 2025-08-13 | 2644.33 | 14.77 |
更多>>
From March 31, 2025 to June 30, 2025
Exercise of Private Pre-Funded Warrants and Common Warrants
Issuance of Common Stock upon restricted stock units vesting
|
2025-06-30 |
| 2025-05-15 | 2617.63 | 未披露 | 定期报告 | 2025-05-11 |
| 2025-03-27 | 2496.61 | 14.77 | 定期报告 | 2025-03-17 |
| 2025-02-27 | 2100.49 | 未披露 |
更多>>
Common Stock Offered 2,828,283 shares by the company.
|
2025-02-27 |
| 2025-03-25 | 1817.67 | 14.77 |
更多>>
From December 31, 2023 to December 31, 2024
Issuance of Common Stock, Merger Warrants and Redeemable Convertible Preferred Shares upon the APT acquisition, net of issuance cost
Issuance of Redeemable Convertible Preferred Shares upon March 2024 PIPE, net of issuance costs
Redeemable Convertible Preferred Shares conversion into shares of Common Stock
Exercise of Pre-Funded Warrants into shares of Common Stock
Issuance of Common Stock under an Open Market Offering Agreement, net of $1 issuance costs
Issuance of Common Stock upon restricted stock units (“RSUs”) vesting
|
2024-12-31 |
| 2024-11-14 | 1817.66 | 14.77 |
更多>>
From June 30, 2024 to September 30, 2024
Redeemable Convertible Preferred Shares conversion into shares of Common Stock
Issuance of Common Stock upon restricted stock units (“RSU”) vesting
|
2024-09-30 |
| 2024-08-16 | 1789.58 | 未披露 |
更多>>
a one-for-ten reverse stock split of the Common Stock
|
2024-08-26 |
| 2024-08-14 | 17895.84 | 未披露 | 定期报告 | 2024-08-12 |
| 2024-08-14 | 6980.64 | 25.69 |
更多>>
From March 31, 2024 to June 30, 2024
Exercise of Pre-Funded Warrants into shares of Common Stock
|
2024-06-30 |
| 2024-05-20 | 6980.64 | 未披露 | 定期报告 | 2024-05-17 |
| 2024-05-20 | 5999.83 | 25.69 |
更多>>
From January 1, 2024 to March 31, 2024
Issuance of Common Stock, Merger Warrants and Redeemable Convertible Preferred Shares upon the APT acquisition, net of issuance cost
Issuance of Common Stock under Open Market Sales Agreement, net of $1 issuance costs
Exercise of Pre-Funded Warrants into shares of Common Stock
|
2024-03-31 |
| 2024-04-04 | 5522.01 | 未披露 | 定期报告 | 2024-03-28 |
| 2024-04-04 | 4597.99 | 未披露 |
更多>>
From December 31, 2022 to December 31, 2023
Issuance of Common Stock under Open Market Sales Agreement
Issuance of Common Stock and warrants under Private Investment in Public Equity (“PIPE”), net of $333 issuance costs
Reissuance of treasury stock
|
2023-12-31 |
| 2023-12-07 | 4597.99 | 未披露 | 定期报告 | 2023-12-05 |
| 2023-11-14 | 4597.40 | 未披露 | 定期报告 | 2023-09-30 |
| 2023-08-09 | 4597.97 | 未披露 | 定期报告 | 2023-08-03 |
| 2023-08-09 | 4597.40 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Issuance of Common Stock and warrants under PIPE, net of $157 issuance costs
|
2023-06-30 |
| 2023-05-15 | 4597.97 | 未披露 | 定期报告 | 2023-05-09 |
| 2023-05-15 | 3317.61 | 未披露 |
更多>>
From January 1, 2023 to March 31, 2023
Issuance of Common Stock and warrants under Private Investment in Public Equity (“PIPE”), net of $176 issuance costs
|
2023-03-31 |
| 2023-03-22 | 3318.18 | 未披露 | 定期报告 | 2023-03-20 |
| 2023-03-29 | 2997.66 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Issuance of Common Stock under Open Market Sales Agreement net of $8 issuance costs
|
2022-12-31 |
| 2022-11-09 | 2998.23 | 未披露 | 定期报告 | 2022-11-04 |
| 2022-11-09 | 2997.66 | 未披露 |
更多>>
From June 30, 2022 to September 30,2022
Issuance of Common Stock under Open Market Sales Agreement net of $7 issuance costs
|
2022-09-30 |
| 2022-08-10 | 2998.23 | 未披露 | 定期报告 | 2022-08-05 |
| 2022-08-10 | 2977.47 | 未披露 | 定期报告 | 2022-06-30 |
| 2022-05-02 | 2978.04 | 未披露 | 定期报告 | 2022-04-26 |
| 2022-04-08 | 3056.06 | 未披露 | 定期报告 | 2022-04-06 |
| 2022-05-11 | 2977.47 | 未披露 |
更多>>
From January 1, 2022 to March 31, 2022
Issuance of Common Stock under Open Market Sales Agreement, net of $1 issuance costs
|
2022-03-31 |
| 2022-03-30 | 2977.92 | 未披露 | 定期报告 | 2022-03-25 |
| 2022-03-30 | 2974.75 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Exercise of stock options
Exercise of warrants
Issuance of Common Stock under Open Market Sales Agreement, net of $158 issuance costs
Issuance of Common Stock under Securities Purchase Agreement (“SPA”), net of $1,235 issuance costs
Issuance of Common Stock under Stock Purchase Agreement with Maruho, net of $52 issuance costs
Issuance of Common Stock under Securities Purchase Agreement with CF Foundation
|
2021-12-31 |
| 2021-11-15 | 2858.12 | 未披露 | 定期报告 | 2021-11-10 |
| 2021-11-15 | 2820.05 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Exercise of stock options
Issuance of Common Stock under Open Market Sales Agreement, net of $2 issuance costs
Issuance of Common Stock under securities purchase agreement (“SPA”), net of $1,235 issuance costs
|
2021-09-30 |
| 2021-07-28 | 2819.46 | 未披露 |
更多>>
1.Common Stock Offered 3,750,000 shares.
2.The number of shares of common stock to be outstanding after the offering is based on 24,444,576 shares outstanding on July 23, 2021.
|
2021-07-28 |
| 2021-07-26 | 2444.46 | 未披露 | 定期报告 | 2021-07-23 |
| 2021-08-16 | 2442.91 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Exercise of stock options
Issuance of Common Stock under Open Market Sales Agreement, net of $24 issuance costs
|
2021-06-30 |
| 2021-05-24 | 2432.67 | 未披露 | 定期报告 | 2021-05-20 |
| 2021-04-30 | 2430.91 | 未披露 | 定期报告 | 2021-04-28 |
| 2021-05-24 | 2424.13 | 未披露 |
更多>>
from January 1, 2021 to March 31, 2021
Issuance of Common Stock under Open Market Sales Agreement, net of $134 issuance costs
Exercise of stock options
Exercise of warrants
|
2021-03-31 |
| 2021-03-31 | 2424.60 | 未披露 | 定期报告 | 2021-03-25 |
| 2021-03-31 | 2326.46 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Acquisition of treasury stock
Effect of Recapitalization Transaction
Exercise of stock options
|
2020-12-31 |
| 2020-12-04 | 2324.71 | 未披露 | 定期报告 | 2020-11-30 |
| 2020-11-12 | 2317.79 | 未披露 | 定期报告 | 2020-11-09 |
| 2020-11-12 | 2316.77 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Exercise of options
|
2020-09-30 |
| 2020-08-13 | 2314.60 | 未披露 | 定期报告 | 2020-08-11 |
| 2020-08-13 | 2314.03 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Exercise of options
|
2020-06-30 |
| 2020-04-21 | 2292.59 | 未披露 | 定期报告 | 2020-04-10 |
| 2020-05-14 | 2292.02 | 未披露 |
更多>>
From December 31, 2019 to March 31, 2020
Exercise of options
|
2020-03-31 |
| 2020-03-26 | 2291.11 | 未披露 | 定期报告 | 2020-03-25 |
| 2020-03-26 | 2286.28 | 未披露 |
更多>>
From December 31, 2018 to December 31, 2019
Effect of reverse recapitalization transaction
Acquisition of treasury stock
Exercise of options
|
2019-12-31 |
| 2019-12-13 | 2204.16 | 未披露 | 定期报告 | 2019-12-03 |
| 2019-12-13 | 2283.52 | 未披露 | 定期报告 | 2019-10-28 |
| 2019-05-10 | 875.00 | 未披露 |
更多>>
from December 31, 2018 to March 31, 2019
Change in value of common stock subject to possible redemption
Forfeiture of Founders Shares
|
2019-03-31 |
| 2019-03-13 | 875.00 | 未披露 | 定期报告 | 2019-03-13 |
| 2018-12-07 | 201.25 | 未披露 | 定期报告 | 2018-12-07 |
a one-for-nineteen reverse split of the Company's common stock
From June 30, 2025 to September 30, 2025
Conversion of Redeemable Convertible Preferred Shares into Common Stock
Exercise of Private Pre-Funded Warrants
Issuance of Common Stock under At the Market Sales Agreement, net of $3 issuance costs
From March 31, 2025 to June 30, 2025
Exercise of Private Pre-Funded Warrants and Common Warrants
Issuance of Common Stock upon restricted stock units vesting
Common Stock Offered 2,828,283 shares by the company.
From December 31, 2023 to December 31, 2024
Issuance of Common Stock, Merger Warrants and Redeemable Convertible Preferred Shares upon the APT acquisition, net of issuance cost
Issuance of Redeemable Convertible Preferred Shares upon March 2024 PIPE, net of issuance costs
Redeemable Convertible Preferred Shares conversion into shares of Common Stock
Exercise of Pre-Funded Warrants into shares of Common Stock
Issuance of Common Stock under an Open Market Offering Agreement, net of $1 issuance costs
Issuance of Common Stock upon restricted stock units (“RSUs”) vesting
From June 30, 2024 to September 30, 2024
Redeemable Convertible Preferred Shares conversion into shares of Common Stock
Issuance of Common Stock upon restricted stock units (“RSU”) vesting
a one-for-ten reverse stock split of the Common Stock
From March 31, 2024 to June 30, 2024
Exercise of Pre-Funded Warrants into shares of Common Stock
From January 1, 2024 to March 31, 2024
Issuance of Common Stock, Merger Warrants and Redeemable Convertible Preferred Shares upon the APT acquisition, net of issuance cost
Issuance of Common Stock under Open Market Sales Agreement, net of $1 issuance costs
Exercise of Pre-Funded Warrants into shares of Common Stock
From December 31, 2022 to December 31, 2023
Issuance of Common Stock under Open Market Sales Agreement
Issuance of Common Stock and warrants under Private Investment in Public Equity (“PIPE”), net of $333 issuance costs
Reissuance of treasury stock
From March 31, 2023 to June 30, 2023
Issuance of Common Stock and warrants under PIPE, net of $157 issuance costs
From January 1, 2023 to March 31, 2023
Issuance of Common Stock and warrants under Private Investment in Public Equity (“PIPE”), net of $176 issuance costs
From December 31, 2021 to December 31, 2022
Issuance of Common Stock under Open Market Sales Agreement net of $8 issuance costs
From June 30, 2022 to September 30,2022
Issuance of Common Stock under Open Market Sales Agreement net of $7 issuance costs
From January 1, 2022 to March 31, 2022
Issuance of Common Stock under Open Market Sales Agreement, net of $1 issuance costs
From December 31, 2020 to December 31, 2021
Exercise of stock options
Exercise of warrants
Issuance of Common Stock under Open Market Sales Agreement, net of $158 issuance costs
Issuance of Common Stock under Securities Purchase Agreement (“SPA”), net of $1,235 issuance costs
Issuance of Common Stock under Stock Purchase Agreement with Maruho, net of $52 issuance costs
Issuance of Common Stock under Securities Purchase Agreement with CF Foundation
From June 30, 2021 to September 30, 2021
Exercise of stock options
Issuance of Common Stock under Open Market Sales Agreement, net of $2 issuance costs
Issuance of Common Stock under securities purchase agreement (“SPA”), net of $1,235 issuance costs
1.Common Stock Offered 3,750,000 shares.
2.The number of shares of common stock to be outstanding after the offering is based on 24,444,576 shares outstanding on July 23, 2021.
From March 31, 2021 to June 30, 2021
Exercise of stock options
Issuance of Common Stock under Open Market Sales Agreement, net of $24 issuance costs
from January 1, 2021 to March 31, 2021
Issuance of Common Stock under Open Market Sales Agreement, net of $134 issuance costs
Exercise of stock options
Exercise of warrants
From December 31, 2019 to December 31, 2020
Acquisition of treasury stock
Effect of Recapitalization Transaction
Exercise of stock options
From June 30, 2020 to September 30, 2020
Exercise of options
From March 31, 2020 to June 30, 2020
Exercise of options
From December 31, 2019 to March 31, 2020
Exercise of options
From December 31, 2018 to December 31, 2019
Effect of reverse recapitalization transaction
Acquisition of treasury stock
Exercise of options
from December 31, 2018 to March 31, 2019
Change in value of common stock subject to possible redemption
Forfeiture of Founders Shares